NEW YORK (GenomeWeb News) – Stem cell technology developer Cellular Dynamics International said today it has inked a collaborative agreement with the Hamner Institute to develop predictive in vitro screening assays to be used in toxicity testing and risk assessment.

The Research Triangle Park, NC-based firm said the human induced pluripotent stem cell assays will enable chemical, environmental, and pharmaceutical toxicology assessments without the use of animal models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.